Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.

Autor: Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine & Health, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK., Walker D; Department of Rheumatology, Northumbria Healthcare NHS Foundation Trust, North Shields, UK., Edwards CJ; Department of Rheumatology and NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Barry J; Medical Affairs Inflammation, UK & Ireland, Galapagos Biotech Ltd, Uxbridge, UK., Akroyd L; Medical Affairs Inflammation, UK & Ireland, Galapagos Biotech Ltd, Uxbridge, UK., Omoruyi EVE; Biostatistics, Galapagos, Mechelen, Belgium, NV., Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.